These genetic disorders result from reduced levels of gonadotropin and sex steroids in the absence of anatomical or functional abnormalities of the hypothalamic–pituitary–gonadal axis.
One of the main treatments for CPP is the use of gonadotropin-releasing hormone analogs (GnRHa), which help to delay the progression of puberty and can positively influence final adult height ...
Gonadotrope cells of the anterior pituitary are essential in controlling reproductive competency of mammals through the release of gonadotropins, lutenizing hormone (LH) and follicle stimulating ...
We are particularly interested in the function of gonadotropin-releasing hormone (GnRH) and the developmental regulation of neurons that produce GnRH, since developmental abnormalities in these ...